Alopecia areata (AA) is a common chronic tissue-specific autoimmune disease, resulting in
hair loss, that affects up to 2% of the general population. The exact pathobiology of AA has …

Platelet-rich plasma (PRP) is currently used in different medical fields. The interest in the
application of PRP in dermatology has recently increased. It is being used in several …

The use of stem cells has been reported to improve hair regrowth in several therapeutic
strategies, including reversing the pathological mechanisms, that contribute to hair loss …

The overall increase of chronic degenerative diseases associated with ageing makes
wound care a tremendous socioeconomic burden. Thus, there is a growing need to develop …

Androgenetic alopecia is the most common hair loss disorder, affecting both men and
women. Initial signs of androgenetic alopecia usually develop during teenage years leading …

Platelet-rich plasma (PRP) has emerged as a new treatment modality in regenerative plastic
surgery, and preliminary evidence suggests that it might have a beneficial role in hair …

Hair follicle stem cells (HFSCs) are among the most widely available resources and most
frequently approved model systems used for studying adult stem cells. HFSCs are …

Hair loss, or alopecia, is associated with several psychosocial and medical comorbidities,
and it remains an economic burden to individuals and the society. Alopecia is attributable to …

Androgenetic alopecia (AGA) is characterized by a non-scarring progressive miniaturization
of the hair follicle in predisposed men and women with a pattern distribution. Although AGA …

Background: Platelet-rich plasma (PRP) is defined as an autologous concentration of
plasma with a greater count of platelets than that of whole blood. Its action depends on the …